Phase I Study to Determine the Safety and Feasibility of the Use of a Combination Stem Cell Therapy in Patients With Acute Myocardial Infarction

Trial Profile

Phase I Study to Determine the Safety and Feasibility of the Use of a Combination Stem Cell Therapy in Patients With Acute Myocardial Infarction

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Apr 2014

At a glance

  • Drugs Autologous stem cell therapy (Primary)
  • Indications Myocardial infarction
  • Focus Adverse reactions
  • Sponsors TCA Cellular Therapy
  • Most Recent Events

    • 21 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top